Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline [Yahoo! Finance]
T. Rowe Price Group, Inc. (TROW)
Last t. rowe price group, inc. earnings: 4/28 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
trow.client.shareholder.com
Company Research
Source: Yahoo! Finance
This capital infusion will accelerate the clinical development of BJT-778, as the treatment for chronic hepatitis D (HDV). The funds will also support the progression of additional promising candidates in Bluejay's robust pipeline for the treatment for chronic hepatitis B. As previously announced, BJT-778 has received PRIME designation from EMA based on early results from the Phase 1/2 study in HDV. This financing round was co-led by Frazier Life Sciences and a life science focused institutional investment firm, with significant contributions from both new and existing investors, including RA Capital Management, T. Rowe Price, Wellington Management, Novo Holdings, RiverVest Venture Partners, Octagon Capital, Arkin Bio Ventures, HBM Healthcare Investments and Unicorn Capital. Following the completion of the Series C financing, Bluejay is excited to welcome New Board Member, Daniel Estes, a General Partner at Frazier, to its Board of Directors. "We are immensely grateful for the r
Show less
Read more
Impact Snapshot
Event Time:
TROW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TROW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TROW alerts
High impacting T. Rowe Price Group, Inc. news events
Weekly update
A roundup of the hottest topics
TROW
News
- Is T. Rowe Price Blue Chip Growth Adviser (PABGX) a Strong Mutual Fund Pick Right Now? [Yahoo! Finance]Yahoo! Finance
- 3 Large-Cap Growth Funds to Buy as Inflation Cools in April [Yahoo! Finance]Yahoo! Finance
- Is T. Rowe Price Japan Fund (PRJPX) a Strong Mutual Fund Pick Right Now? [Yahoo! Finance]Yahoo! Finance
- EveryLife Foundation Announces Scientific Workshop on 'Ultra-Rare' Diseases [Yahoo! Finance]Yahoo! Finance
- Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
TROW
Earnings
- 4/26/24 - Beat
TROW
Sec Filings
- 5/10/24 - Form N-CEN
- 5/10/24 - Form N-CEN
- 5/10/24 - Form N-CEN
- TROW's page on the SEC website